Ligand Financial Statements From 2010 to 2026

Ligand Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 1.1 B 1.1 B 739.4 M Slightly volatile Short and Long Term Debt Total 7.8 M 8.2 M 187.1 M Very volatile Other Current Liabilities 24.8 M 31.6 M 19.3 M Slightly volatile Total Current Liabilities 74.3 M 42.7 M 66.9 M Very volatile Total Stockholder Equity 1 B 955 M 481 M Slightly volatile Property Plant And Equipment Net 30 M 28.5 M 14.2 M Slightly volatile Accounts Payable 7.3 M 4.7 M 7 M Slightly volatile Cash 88.7 M 83.2 M 113.1 M Very volatile Non Current Assets Total 736.8 M 701.7 M 416.1 M Slightly volatile Cash And Short Term Investments 180.2 M 294.6 M 262.5 M Slightly volatile Net Receivables 51.3 M 48.8 M 33.4 M Slightly volatile Common Stock Shares Outstanding 16.3 M 21 M 18.7 M Pretty Stable Liabilities And Stockholders Equity 1.1 B 1.1 B 739.4 M Slightly volatile Non Current Liabilities Total 81.1 M 85.4 M 192.9 M Pretty Stable Other Current Assets 10.4 M 16.9 M 9 M Very volatile Other Stockholder Equity 588.5 M 388 M 515.6 M Slightly volatile Total Liabilities 251.5 M 128 M 265.4 M Pretty Stable Property Plant And Equipment Gross 39.9 M 38 M 14.6 M Slightly volatile Total Current Assets 222 M 381.3 M 312.9 M Slightly volatile Short Term Debt 1.4 M 1.5 M 46.7 M Pretty Stable Inventory 17 M 16.2 M 10.1 M Slightly volatile Common Stock Total Equity 14.5 K 15.3 K 23.3 K Slightly volatile Short Term Investments 124.7 M 211.4 M 177.2 M Slightly volatile Common Stock 17.1 K 18 K 23.9 K Slightly volatile Other Liabilities 43.3 M 64.4 M 40.3 M Slightly volatile Other Assets 14.5 M 15.3 M 40.6 M Very volatile Intangible Assets 322 M 306.6 M 177.9 M Slightly volatile Property Plant Equipment 33.2 M 31.6 M 13.4 M Slightly volatile Good Will 121.7 M 121 M 124.9 M Pretty Stable Long Term Debt Total 259.4 M 368.8 M 220.9 M Slightly volatile Capital Surpluse 493.2 M 335.7 M 571.6 M Slightly volatile Non Current Liabilities Other 21.5 M 20.4 M 19.8 M Pretty Stable Deferred Long Term Asset Charges 114.8 M 142.5 M 114.1 M Slightly volatile Short and Long Term Debt 125.1 M 69 M 135.3 M Slightly volatile Warrants 23.5 M 17 M 27 M Slightly volatile Net Invested Capital 774.6 M 747.4 M 810 M Slightly volatile Capital Stock 14.4 K 18 K 19.2 K Slightly volatile Capital Lease Obligations 8.4 M 6.4 M 10.5 M Slightly volatile
Ligand Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 42.6 M 40.5 M 22.2 M Slightly volatile Total Revenue 102.9 M 192.2 M 122.2 M Slightly volatile Other Operating Expenses 131.8 M 218.2 M 131.9 M Slightly volatile Cost Of Revenue 19.1 M 12.7 M 18 M Slightly volatile Research Development 31.3 M 19.3 M 25.6 M Slightly volatile Selling General Administrative 50.8 M 90.5 M 40.6 M Slightly volatile Selling And Marketing Expenses 12.2 M 13.7 M 15 M Slightly volatile Non Recurring 836.3 K 928.8 K 1 M Slightly volatile Interest Income 10.7 M 7.2 M 13.9 M Slightly volatile Reconciled Depreciation 34.7 M 40.5 M 24.1 M Slightly volatile
Ligand Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 50.2 M 26.4 M 43.4 M Pretty Stable Depreciation 42.6 M 40.5 M 22.5 M Slightly volatile Capital Expenditures 23.7 M 22.6 M 13.6 M Slightly volatile End Period Cash Flow 52.7 M 83.2 M 51.3 M Pretty Stable Stock Based Compensation 49.6 M 47.3 M 24.7 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 9.27 10.55 13.6474 Slightly volatile Dividend Yield 0.0558 0.0588 0.0802 Slightly volatile PTB Ratio 2.02 2.12 8.9246 Slightly volatile Days Sales Outstanding 73.88 83.43 88.4883 Pretty Stable Book Value Per Share 42.91 40.86 25.2791 Slightly volatile Stock Based Compensation To Revenue 0.13 0.22 0.1641 Slightly volatile Capex To Depreciation 0.72 0.5 1.1199 Slightly volatile PB Ratio 2.02 2.12 8.9246 Slightly volatile EV To Sales 9.82 10.2 14.3411 Slightly volatile Payables Turnover 2.23 1.9 4.2679 Pretty Stable Sales General And Administrative To Revenue 0.65 0.54 0.3689 Slightly volatile Research And Ddevelopement To Revenue 0.14 0.15 0.2982 Slightly volatile Capex To Revenue 0.12 0.14 0.1157 Pretty Stable Cash Per Share 7.94 12.61 13.5654 Slightly volatile Days Payables Outstanding 134 155 208 Slightly volatile Intangibles To Total Assets 0.3 0.36 0.4341 Pretty Stable Current Ratio 4.74 8.04 9.3499 Pretty Stable Receivables Turnover 6.92 4.53 4.9288 Slightly volatile Shareholders Equity Per Share 42.91 40.86 25.2846 Slightly volatile Debt To Equity 0.0073 0.0077 1.1879 Slightly volatile Capex Per Share 0.53 0.97 0.6799 Slightly volatile Revenue Per Share 5.35 8.22 6.6055 Slightly volatile Interest Debt Per Share 0.47 0.5 10.2896 Very volatile Debt To Assets 0.0082 0.0087 0.2693 Slightly volatile Graham Number 37.22 47.19 43.4278 Slightly volatile Operating Cycle 527 502 306 Slightly volatile Price Book Value Ratio 2.02 2.12 8.9246 Slightly volatile Days Of Payables Outstanding 134 155 208 Slightly volatile Company Equity Multiplier 1.44 1.02 2.9675 Slightly volatile Long Term Debt To Capitalization 0.31 0.32 0.4033 Slightly volatile Total Debt To Capitalization 0.0093 0.0098 0.3351 Slightly volatile Debt Equity Ratio 0.0073 0.0077 1.1879 Slightly volatile Quick Ratio 4.66 7.7 9.1121 Pretty Stable Cash Ratio 1.41 1.75 2.4259 Very volatile Days Of Sales Outstanding 73.88 83.43 88.4883 Pretty Stable Price To Book Ratio 2.02 2.12 8.9246 Slightly volatile Fixed Asset Turnover 5.76 6.06 40.0967 Slightly volatile Debt Ratio 0.0082 0.0087 0.2693 Slightly volatile Price Sales Ratio 9.27 10.55 13.6474 Slightly volatile Asset Turnover 0.32 0.2 0.2225 Slightly volatile Price Fair Value 2.02 2.12 8.9246 Slightly volatile
Ligand Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 3.1 B 2.9 B 2.4 B Slightly volatile Enterprise Value 3 B 2.9 B 2.3 B Slightly volatile

Ligand Fundamental Market Drivers

Ligand Upcoming Events

About Ligand Pharmaceuticals Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ligand Pharmaceuticals is a strong investment it is important to analyze Ligand Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ligand Pharmaceuticals' future performance. For an informed investment choice regarding Ligand Stock, refer to the following important reports:

How To Invest In Ligand Details

Is Ligand Stock a good investment? Details

What is Ligand Pharmaceuticals' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details